WuXi AppTec Continued Solid Growth in First-Quarter of 2023

/PRNewswire/ -- WuXi AppTec (stock code: 603259.SH / 2359.HK), a global company that provides a broad portfolio of R&D and manufacturing services that enable...

Related Keywords

Germany , China , Wuxi , Jiangsu , Lingang , Jiangxi , Shanghai , Hong Kong , United States , America , Asia Pacific , National Medical Products Administration , Quarter Report Of The Company , Accounting Standard For Business Enterprises , Manufacturing Organization , Stock Exchange Of Hong Kong , Modalities Related Services , Site Management Organization , Shanghai Stock Exchange , Owners Of The Company , Contract Research , Lab Testing Services Drives Steady Growth , International Financial Reporting Standards , Profit Attributable , Turned Positive , Grew Strongly , Wuxi Apptec , Quarter Report , Stock Exchange , Accounting Standard , Business Enterprises , Contract Testing , Reporting Period , Model Drives Steady Growth , Continuous Expansion , New Modalities Related Services , Wuxi Chemistry , Lab Testing Services Drives Steady , Wuxi Testing , Strong Contribution , New Modalities Related , Wuxi Biology , Model Drives , Shanghai Lingang , Biological License Application , Tumor Infiltrating Lymphocyte , Lenti Viral Vector , Pre Approval Inspection , Drug Inspection , First Year , Receive New Drug Application , New Drugs Developed , Trial Approvals , Financial Position , Net Profit Attributable , North America ,